Mon. Nov 29th, 2021


Madrid

Updated:

Keep

A total of 27 new research projects will receive funding through the
XVIII Aid for Health Research from the Mutua Madrileña Foundation
.

The projects will be carried out in the areas of improvement pathways for transplants (6 studies), traumatology and its sequelae (6 studies), rare diseases that manifest in childhood (5 studies), oncology focused in this edition on prostate cancer (3 studies) and Covid-19 (4 studies). In addition, another 3 studies will be financed led by specialists from the medical staff of Adeslas, a leading insurance company in health insurance and belonging to the Mutua Madrileña Group.

The foundation will support with two million euros in aid to launch these investigations.

The delivery of its Health Research Grants were held in Madrid, in an event chaired by the president of the Mutua Group and its foundation, Ignacio Garralda, the president of the Scientific Committee of the Mutua Madrileña Foundation, Dr. Rafael Matesanz, and the Professor Emilio Bouza, Professor of Microbiology.

Precisely Dr. Bouza referred to the Covid-19 pandemic and recalled that what had been learned throughout the history of other epidemics has served to deal with it. “What have we learned? solidarity, ability to face things, scientific and assistance organization. The possibility of making a vaccine in 1 year -he recalled- is the result of collaboration between governments, the scientific world and the company».

This effort, he said, is showing that vaccines confer 90% protection and that, poop, “it seems clearer that the efficacy of vaccines may be longer than we had thought.”

What have we learned? solidarity, ability to face things, scientific and assistance organization

This year two projects are financed in the category of cooperative projects between research centers from different autonomous communities. In total, taking into account all the hospitals that will participate in the collaborative projects, the Mutua Foundation will support the work of research teams from 24 hospitals in 11 autonomous communities.

In the first of these, centers in Madrid, Santander, Barcelona and Bilbao are collaborating to use liquid donor biopsy to search for markers that predict long-term kidney function after transplantation.

In the second of the collaborative studies, in the area of ​​rare diseases, the
Vall d’Hebron-IR-HUVH University Hospital Research Institute
, will develop a gene therapy strategy to correct a mutation that causes an ultra rare disease that affects around thirty children in the world, together with hospitals of Madrid, Aragon and Navarra. If the strategy is validated, it could be implemented in other diseases.

This year the call for grants included a specific category for studies aimed at improving knowledge or seeking treatments for Covid-19

This year the call for grants included a specific category for studies aimed at improving knowledge or seeking treatments for Covid-19. Among other aspects, the effectiveness of the vaccine in immunosuppressed patients and the need or not for an early booster dose o A new diagnostic method for SARS-CoV-2 based on the CRISPR gene editing technique will be developed.

In the field of transplants, the studies that will validate the use of artificial intelligence in donor-recipient matching in transplants to improve survival and increase the number of organs available stand out.

On the other hand, in erare diseases the involvement of the microbiota and the small intestine in patients with bone marrow transplantation and graft-versus-host disease (GVHD) will be studied and a technique will be validated to include the detection of a rare disease, X-linked adrenoleukodystrophy, using the collected samples neonates in the so-called heel test.

Finally, in the area of ​​Oncology, this year focused on prostate cancer, three studies will be financed.

Finally, Dr. Bouza reminded the Foundation: «don’t forget about infectious diseases».

See them
comments


www.abc.es

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *